Expanded screening using the Vaidya & Carey algorithm significantly improved primary aldosteronism detection in patients with ...

Hypertension affects 1 in 3 adults globally and is the leading modifiable risk factor for cardiovascular disease. Aldosterone ...

A large number of hypertension patients may unknowingly suffer from primary aldosteronism (PA) — a common but underdiagnosed ...

A novel integrated molecular imaging approach enables precise localization and quantification of heart damage, as well as ...

Primary hyperaldosteronism ultimately was diagnosed in 45 patients; the other 17 were presumed to have essential hypertension. After reviewing all ARR results, the authors conclude that testing ...

Hypertension affects one in three adults globally and is the leading modifiable risk factor for cardiovascular disease.

Results from a clinical trial of a novel aldosterone synthase inhibitor, lorundrostat, found it significantly reduces ...

The aldosterone-renin screening market is forecasted to grow from USD 574.8 million in 2025 to USD 1,109.7 million by 2035, at a CAGR of 6.8% during the forecast period. The aldosterone-renin ...

Primary hyperaldosteronism, commonly due to either an aldosterone-producing adrenal adenoma or bilateral adrenal hyperplasia, is one of the most common causes of secondary hypertension. One report ...

Secondary forms of metabolic dysfunction-associated steatotic liver disease (MASLD) have different pathogeneses, ...